{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:52:43Z","timestamp":1792363963897,"version":"4.4.0"},"reference-count":32,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-01228"],"award-info":[{"award-number":["2021-01228"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["23 2915 Pj"],"award-info":[{"award-number":["23 2915 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009240","name":"Swedish association of local authorities and regions","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009240","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Med Screen"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Comparisons and optimization of screening programs are based on quality indicators (QI), but these are not well standardized and commonly not published. We report 13 QIs used for cervical screening in Sweden. These are decided on by the authorities and reported by the Swedish National Cervical Screening Registry that collects all data and calculates the QIs. The QIs as well as trends discovered and observations made during recent years, including effects of the COVID-19 pandemic, are summarized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Sweden. All units involved in cervical screening export all individual data to the screening registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All data on screening invitations, cervical samples with human papillomavirus (HPV), cytology and histopathology results, as well as population data, cervical cancer cases and mortality, were collected. The 13 QIs were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The HPV screening test had a high population coverage of 83%, with most primary screenings using self-sampling. Follow-up for women with CIN2+ (cervical intraepithelial neoplasia) in cytology within 3 months was 60%, increasing to 95% or more after 1 year. The incidence and mortality of cervical cancer have decreased in recent years. Some QIs became outdated due to program changes, and there was significant variability between regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The population coverage of the HPV screening test was not affected by the cancellation of screening appointments during the pandemic, because of switching to primary self-sampling. Improving follow-up of screen-positives and boosting population test coverage using HPV self-sampling are key areas for potential improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09691413251362597","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:50:36Z","timestamp":1753948236000},"page":"84-93","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Quality indicators for cervical screening in Sweden"],"prefix":"10.1177","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9980-6937","authenticated-orcid":false,"given":"Helena","family":"Andersson","sequence":"first","affiliation":[{"name":"Karolinska University Hospital"},{"name":"Karolinska Institutet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-7497","authenticated-orcid":false,"given":"Sara","family":"Nordqvist Kleppe","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital"},{"name":"Karolinska Institutet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1649-8024","authenticated-orcid":false,"given":"Henrik","family":"Edvardsson","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Miriam","family":"Elfstr\u00f6m","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital"},{"name":"Karolinska Institutet"},{"name":"Regional Cancer Center of Stockholm-Gotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8588-6506","authenticated-orcid":false,"given":"Joakim","family":"Dillner","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital"},{"name":"Karolinska Institutet"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.12.013"},{"key":"e_1_3_3_3_2","unstructured":"European Parliamentary Forum for Sexual & Reproductive Rights. Cervical cancer prevention policy atlas https:\/\/www.epfweb.org\/node\/1029 (June 2023 accessed 2 January 2024)."},{"key":"e_1_3_3_4_2","unstructured":"National Board of Health and Welfare. Indicators \u2013 screening for cervical cancer. 2022."},{"key":"e_1_3_3_5_2","isbn-type":"print","volume-title":"European guidelines for quality assurance in cervical cancer screening","author":"European Commission","year":"2008","unstructured":"European Commission. European guidelines for quality assurance in cervical cancer screening. 2nd ed. Luxembourg: Office for Official Publications of the European Communities, 2008. ISBN 978-92-79-07698-5.","ISBN":"https:\/\/id.crossref.org\/isbn\/9789279076985","edition":"2"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/0969141316632023"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209003"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181577654"},{"key":"e_1_3_3_9_2","unstructured":"National Board of Health and Welfare. Screening for cervical cancer \u2013 recommendation and assessment documentation. 2015."},{"key":"e_1_3_3_10_2","volume-title":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention","year":"2021","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. Geneva: World Health Organization, 2021.","edition":"2"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/09691413221092246"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32374"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.14729"},{"key":"e_1_3_3_14_2","unstructured":"National Board of Health and Welfare. Screening for Cervical Cancer \u2013 recommendation to offer screening. Final version 2022. 2022."},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf032"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.101156"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00218-4"},{"key":"e_1_3_3_18_2","unstructured":"SoS \u201cNational evaluation of cervical screening\u201d from 2020."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32416"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00501-0"},{"key":"e_1_3_3_21_2","article-title":"Lives saved through increasing adherence to follow-up after abnormal cervical cancer screening results","volume":"1","author":"Harper DM","year":"2024","unstructured":"Harper DM, Yu TM, Fendrick AM. Lives saved through increasing adherence to follow-up after abnormal cervical cancer screening results. O G Open 2024; 1: e001.","journal-title":"O G Open"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad028"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2017.1355110"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2024-003019"},{"key":"e_1_3_3_25_2","unstructured":"Cervical screening standards data report 2021 to 2022. Cervical screening standards data report 2021 to 2022 - GOV.UK. (25 April 2023 accessed 29 March 2025)."},{"key":"e_1_3_3_26_2","volume-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","year":"2020","unstructured":"Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health Organization, 2020. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"e_1_3_3_27_2","unstructured":"Australian Institute of Health and Welfare. National Cervical Screening Program monitoring report 2023. Catalogue number CAN 157 AIHW Australian Government 2023."},{"key":"e_1_3_3_28_2","unstructured":"Brotherton J Machalek D Smith M et al. 2024 Cervical Cancer Elimination Progress Report: Australia\u2019s progress towards the elimination of cervical cancer as a public health problem. Melbourne Australia 2025. https:\/\/www.cervicalcancercontrol.org.au."},{"key":"e_1_3_3_29_2","volume-title":"Cervical cancer screening in Canada","author":"Canadian Partnership Against Cancer","unstructured":"Canadian Partnership Against Cancer. Cervical cancer screening in Canada. Toronto, ON: Canadian Partnership Against Cancer, 2016 July."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2024.12.010"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2020.1764095"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000515912"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34723"}],"container-title":["Journal of Medical Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413251362597","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09691413251362597","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413251362597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T09:47:16Z","timestamp":1779875236000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09691413251362597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1177\/09691413251362597"],"URL":"https:\/\/doi.org\/10.1177\/09691413251362597","relation":{},"ISSN":["0969-1413","1475-5793"],"issn-type":[{"value":"0969-1413","type":"print"},{"value":"1475-5793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}